Endometrial and Ovarian Cancer with MR Imaging Importance of Serum HE4 and CA 125 Levels in the Extent of Disease at Evaluation
Özet
Objective: Currently, no clinically useful tumor marker is available for primary diagnosis in endometrial cancer. Human epididymis protein-4 (HE-4) has high sensitivity and specificity as a tumor marker. Further, HE-4 has been shown to be elevated in early stage endometrial cancer and is more sensitive than CA 125. In our study, CA 125 and HE-4 reputation as a tumor marker for diagnosis of ovarian and endometrial cancer with the use of both the availability and affect the way we investigated the rate of diagnosis.
Anahtar kelimeler
Sürdürülebilir Kalkınma Amaçları
-
SKA 3: Sağlıklı Bireyler
Atıf için künye
Topdağı Yılmaz, E. P., & KUMTEPE, Y. (2016). Endometrial and Ovarian Cancer with MR Imaging Importance of Serum HE4 and CA 125 Levels in the Extent of Disease at Evaluation. EURASIAN JOURNAL OF MEDICINE, 48(3), 192–198. https://doi.org/10.5152/eurasianjmed.2016.0259
BibTeX
@article{topdagiyilmaz2016-238751,
author = {Topdağı Yılmaz, Emsal Pınar and KUMTEPE, Yakup},
title = {Endometrial and Ovarian Cancer with MR Imaging Importance of Serum HE4 and CA 125 Levels in the Extent of Disease at Evaluation},
journal = {EURASIAN JOURNAL OF MEDICINE},
year = {2016},
volume = {48},
number = {3},
pages = {192--198},
issn = {1308-8734},
doi = {10.5152/eurasianjmed.2016.0259},
url = {https://akademik.atauni.edu.tr/yayinlar/238751-endometrial-and-ovarian-cancer-with-mr-imaging-importance-of-serum-he4-and-ca}
}